0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Toxicology
 41-60 of 942 Articles
JAMA Internal Medicine | 
Research Letter | 
Christopher M. Jones, PharmD, MPH; Peter G. Lurie, MD, MPH; Douglas C. Throckmorton, MD
JAMA Intern Med. 2016;176(3):399-402. doi:10.1001/jamainternmed.2015.7799.

JAMA Oncology | 
Editor's Note |  FREE
Charles R. Thomas Jr, MD, PhD
JAMA Oncol. 2016;2(3):367-368. doi:10.1001/jamaoncol.2015.4087.

JAMA Oncology | 
Invited Commentary | 
David Cella, PhD
JAMA Oncol. 2016;2(3):368-369. doi:10.1001/jamaoncol.2015.4683.

JAMA Oncology | 
Original Investigation | 
Benjamin Movsas, MD; Chen Hu, PhD; Jeffrey Sloan, PhD, HSR; et al.
JAMA Oncol. 2016;2(3):359-367. doi:10.1001/jamaoncol.2015.3969.
Includes: Supplemental Content

JAMA Dermatology | 
Research Letter | 
Kai-Lung Chen, MD; Chia-Chi Lin, MD, PhD; Yung-Tsu Cho, MD; et al.
JAMA Dermatol. 2016;152(3):340-342. doi:10.1001/jamadermatol.2015.4448.

JAMA Oncology | 
Research Letter | 
Hyun Kim, MD; Tu D. Dan, MD; Joshua D. Palmer, MD; et al.
JAMA Oncol. 2016;2(3):390-391. doi:10.1001/jamaoncol.2015.4833.

JAMA | 
News From the Centers for Disease Control and Prevention | 
JAMA. 2016;315(6):550. doi:10.1001/jama.2016.0085.

JAMA Oncology | 
Editor's Note |  FREE
Mary L. Disis, MD
JAMA Oncol. 2016;2(2):241. doi:10.1001/jamaoncol.2015.4717.

JAMA Oncology | 
Original Investigation | 
Shelli R. Kesler, PhD; Douglas W. Blayney, MD
JAMA Oncol. 2016;2(2):185-192. doi:10.1001/jamaoncol.2015.4333.
Includes: Supplemental Content

JAMA Oncology | 
Original Investigation | 
Douglas B. Johnson, MD; Ryan J. Sullivan, MD; Patrick A. Ott, MD, PhD; et al.
JAMA Oncol. 2016;2(2):234-240. doi:10.1001/jamaoncol.2015.4368.
Includes: Supplemental Content

JAMA Dermatology | 
Observation | 
Veronica J. Shi, BA; Anjela Galan, MD; Ian D. Odell, MD, PhD; et al.
JAMA Dermatol. 2016;152(2):222-223. doi:10.1001/jamadermatol.2015.3209.

JAMA Oncology | 
JAMA Oncology Diagnostic Test Interpretation | 
Nibal Rizk, MD; Carlos Kamiya-Matsuoka, MD; Ivo W. Tremont-Lukats, MD
JAMA Oncol. 2016;2(2):265-266. doi:10.1001/jamaoncol.2015.4301.

JAMA Oncology | 
Editorial | 
Gérard Milano, PhD; Emmanuel Chamorey, PharmD, PhD; Jean-Marc Ferrero, MD, PhD
JAMA Oncol. 2016;2(1):21-22. doi:10.1001/jamaoncol.2015.3866.

JAMA Oncology | 
Original Investigation | 
Chau Dang, MD; Hao Guo, MS; Julie Najita, PhD; et al.
JAMA Oncol. 2016;2(1):29-36. doi:10.1001/jamaoncol.2015.3709.
Includes: Supplemental Content

JAMA Internal Medicine | 
Viewpoint | 
Aileen P. Wright, BSc; William C. Becker, MD; Gordon D. Schiff, MD
JAMA Intern Med. 2016;176(1):7-8. doi:10.1001/jamainternmed.2015.5946.
Includes: CME

JAMA Neurology | 
Viewpoint | 
Axel Montagne, PhD; Arthur W. Toga, PhD; Berislav V. Zlokovic, MD, PhD
JAMA Neurol. 2016;73(1):13-14. doi:10.1001/jamaneurol.2015.2960.

JAMA Oncology | 
Invited Commentary | 
Rashmi Chugh, MD; Scott M. Schuetze, MD, PhD
JAMA Oncol. 2015;1(9):1280-1281. doi:10.1001/jamaoncol.2015.3221.

JAMA Oncology | 
Original Investigation |  Open Access
Sant P. Chawla, MD; Zsuzsanna Papai, MD; Guzel Mukhametshina, MD; et al.
JAMA Oncol. 2015;1(9):1272-1280. doi:10.1001/jamaoncol.2015.3101.
Includes: Supplemental Content

JAMA Oncology | 
Review | 
Rebecca M. Prince, MBBS, FRACP; Eshetu G. Atenafu, MSc, PStat; Monika K. Krzyzanowska, MD, MPH, FRCPC
JAMA Oncol. 2015;1(9):1333-1339. doi:10.1001/jamaoncol.2015.3440.
Includes: Supplemental Content

JAMA Dermatology | 
Case Report/Case Series | 
Allison L. Goddard, MD; Ruth Ann Vleugels, MD, MPH; Nicole R. LeBoeuf, MD, MPH; et al.
JAMA Dermatol. 2015;151(12):1354-1357. doi:10.1001/jamadermatol.2015.3028.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Original Investigation  | 
Association of Survival Benefit With Docetaxel in Prostate Cancer and Total Number of Cycles Administered A Post hoc Analysis of the Mainsail Study
Ellen S. de Morrée, MSc; Nicholas J. Vogelzang, MD; Daniel P. Petrylak, MD; et al.
JAMA Cardiology
Review  | 
Oncocardiology—Past, Present, and Future A Review
Edward T. H. Yeh, MD; Hui-Ming Chang, MD, MPH
JAMA Oncology
Viewpoint  | 
Direct-to-Consumer Drug Advertising in Oncology Is Not Beneficial to Patients or Public Health
Lowell E. Schnipper, MD; Gregory A. Abel, MD, MPH
JAMA Internal Medicine
Invited Commentary  | 
Counterfeit Medications and Fentanyl
Traci C. Green, PhD, MSc; Michael Gilbert, MPH